Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lauren Hertan, M.D.

Concepts (118)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Palliative Care13202436431.040 Why?
Bone Neoplasms4202425650.560 Why?
Goals120227170.550 Why?
Radiation Oncology320185720.520 Why?
Spinal Neoplasms220187150.460 Why?
Cancer Care Facilities120164270.410 Why?
Pain Measurement1202035830.340 Why?
Benzopyrans12009630.320 Why?
JNK Mitogen-Activated Protein Kinases120094400.280 Why?
Pain2202251000.270 Why?
Mortality1201729110.260 Why?
Curcumin32012970.260 Why?
Radiotherapy3201715020.250 Why?
Boronic Acids120099150.240 Why?
Nitriles120099800.220 Why?
Pyrazines1200912050.210 Why?
Endoplasmic Reticulum1200911330.210 Why?
Neoplasms62022223710.200 Why?
Qualitative Research3202231400.190 Why?
Lewy Body Disease120232540.180 Why?
Lung Neoplasms22022135860.180 Why?
Radiation-Sensitizing Agents220123480.160 Why?
Glioblastoma2202534640.160 Why?
Practice Guidelines as Topic1201674540.150 Why?
Thioredoxin Reductase 132012320.140 Why?
Prostatic Neoplasms12014111010.090 Why?
Spinal Fractures120187100.090 Why?
Joint Instability120188030.090 Why?
Nanocapsules12011950.080 Why?
Radiation Tolerance120124760.080 Why?
Carcinoma, Pancreatic Ductal1202117570.080 Why?
Antineoplastic Combined Chemotherapy Protocols12009118780.070 Why?
Decision Making1202139530.070 Why?
Humans2320257681660.070 Why?
Neurosurgical Procedures1201720760.070 Why?
Neoplasm Recurrence, Local1202594190.070 Why?
Papillomaviridae1201211400.060 Why?
Patient Selection1201842600.060 Why?
Medulloblastoma120116830.060 Why?
Protease Inhibitors120097510.060 Why?
Radiotherapy, Intensity-Modulated120117980.060 Why?
Aged920251715040.060 Why?
Carcinoma, Squamous Cell2201240580.060 Why?
Radiosurgery1201413300.060 Why?
Drug Synergism1200917600.060 Why?
Survival Analysis12017101010.060 Why?
Male1020253647190.060 Why?
Antineoplastic Agents32012136760.060 Why?
Middle Aged920252234920.050 Why?
Quality of Life22022134900.050 Why?
Prognosis22022300100.050 Why?
Aged, 80 and over52020596290.050 Why?
Pancreatic Neoplasms1202154460.050 Why?
Lewy Bodies120231410.050 Why?
Brain Neoplasms2202591180.050 Why?
Endometrial Neoplasms1201113820.050 Why?
Female1020253971920.050 Why?
Prospective Studies32020549260.050 Why?
Adult620252236460.040 Why?
Giant Cells120211870.040 Why?
Neoplasm Metastasis2202149120.040 Why?
Lymphoma, Large B-Cell, Diffuse1200914370.040 Why?
Enzyme Inhibitors1200937280.040 Why?
Cultural Characteristics120192500.040 Why?
Death120226830.040 Why?
Head and Neck Neoplasms1201229310.040 Why?
Osteoclasts120217130.030 Why?
Referral and Consultation2202036200.030 Why?
Morals120192880.030 Why?
Glioma1201135030.030 Why?
Spirituality120194300.030 Why?
Body Mass Index12011130530.030 Why?
Patient Care Planning120199050.030 Why?
Combined Modality Therapy1202585420.030 Why?
Patient Participation1202114470.020 Why?
Radiotherapy Dosage1201829160.020 Why?
Spine1201811400.020 Why?
Health Care Surveys1201724340.020 Why?
Chemoprevention120123270.020 Why?
Signal Transduction22011236450.020 Why?
Solubility1201110830.020 Why?
Receptor, IGF Type 1120113840.020 Why?
Mitogen-Activated Protein Kinase 3120104740.020 Why?
Mitogen-Activated Protein Kinase 1120104780.020 Why?
Orthopedic Procedures1201812790.020 Why?
Physician-Patient Relations1202132690.020 Why?
Retrospective Studies32022817620.020 Why?
Communication1202139050.020 Why?
Radiotherapy, Adjuvant1201117910.020 Why?
Statistics, Nonparametric1201128620.020 Why?
Mice, Nude1201236230.020 Why?
Socioeconomic Factors1201978520.020 Why?
Gene Knockdown Techniques1201016060.020 Why?
Sex Factors12019106320.020 Why?
Terminal Care1201717700.020 Why?
Cell Line, Tumor22012171400.010 Why?
Massachusetts1201788900.010 Why?
Enzyme Activation1201035900.010 Why?
HeLa Cells1201030740.010 Why?
Polymers1201116300.010 Why?
Glycoproteins1201122020.010 Why?
Regression Analysis1201163400.010 Why?
Body Composition1201124620.010 Why?
Reactive Oxygen Species1201021490.010 Why?
Antigens, CD1201140350.010 Why?
Cell Transformation, Neoplastic1201028460.010 Why?
Molecular Targeted Therapy1201128300.010 Why?
Peptides1201143540.010 Why?
Treatment Outcome12025653710.010 Why?
Risk Assessment12018243150.010 Why?
Animals320141692460.010 Why?
Brain12023273600.010 Why?
Apoptosis1201095230.010 Why?
Disease Models, Animal12012183490.010 Why?
Young Adult12018600660.010 Why?
United States12017730390.010 Why?
Obesity12011130900.010 Why?
Mice12012820290.000 Why?
Hertan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (118)
Explore
_
Co-Authors (34)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.